How Much Did Verily Raise?
Funding & Key Investors

Verily Life Sciences LLC, a prominent subsidiary of Alphabet Inc., has solidified its market position through a series of significant capital injections, culminating in a total funding volume of $3.8B. The company recently secured a major strategic investment of $300M, underscoring its ongoing commitment to advancing precision health through sophisticated data analytics and clinical research infrastructure. This latest infusion of capital reflects the firm's transition into a mature enterprise-level entity, capable of leveraging deep-tech synergies to address complex biomedical challenges on a global scale.

Since its inception, Verily has demonstrated a consistent trajectory of growth, attracting high-caliber institutional backing that validates its unique approach to digital health. By integrating large-scale health data with advanced software platforms, the organization continues to bridge the gap between academic research and commercial clinical application, positioning itself as a critical player in the evolving healthcare technology landscape.

What is Verily?

Verily
SoftwareHealthcare SoftwareBusiness Services

Verily Life Sciences operates at the intersection of technology and medicine, functioning as a specialized unit within the Alphabet ecosystem. The company focuses on the development of software platforms, analytics tools, and clinical research systems designed to synthesize and interpret vast quantities of biomedical data. By prioritizing data-driven research, Verily aims to improve health outcomes and streamline the delivery of clinical care. Its market position is defined by its ability to leverage the computational power and machine learning expertise of its parent company, Alphabet, to solve systemic inefficiencies in the healthcare sector. The firm's portfolio includes a diverse array of digital health solutions that facilitate precision medicine, population health management, and the acceleration of clinical trials, making it a cornerstone of modern health-tech innovation.

How much funding has Verily raised?

Verily has raised a total of $3.8B across 5 funding rounds:

2017

Private Equity

$800M

2019

Other Financing Round

$1B

2020

Private Equity

$700M

2022

Unspecified

$1B

2026

Other Financing Round

$300M

Private Equity (2017): $800M with participation from Temasek

Other Financing Round (2019): $1B led by Ontario Teachers' Pension Plan, Alphabet, Silver Lake, and Temasek

Private Equity (2020): $700M supported by Alphabet, Inc., Temasek, Silver Lake Management, L.L.C., and Ontario Teachers' Pension Plan

Unspecified (2022): $1B featuring Alphabet

Other Financing Round (2026): $300M backed by Alphabet, University of Colorado Anschutz Medical Campus, and UCHealth

Key Investors in Verily

Alphabet

Alphabet Inc. is a multinational technology holding company that serves as the parent organization for Google and various moonshot research initiatives, providing the foundational infrastructure and AI expertise for Verily.

Temasek

Temasek is a Singapore-based global investment firm that acts as a generational investor, focusing on long-term value creation across diverse sectors including life sciences and technology.

Ontario Teachers' Pension Plan

The Ontario Teachers' Pension Plan is a major Canadian institutional investor that manages pension funds and seeks stable, long-term growth through strategic investments in innovative technology and healthcare enterprises.

What's next for Verily?

Looking ahead, the recent strategic investment is expected to catalyze Verily's expansion into new clinical domains and enhance its existing suite of digital health tools. With a focus on scaling its enterprise-level operations, the company is well-positioned to deepen its collaborations with academic medical centers and healthcare systems, such as the University of Colorado Anschutz Medical Campus and UCHealth. This strategic alignment suggests a shift toward more integrated, real-world evidence generation and the deployment of AI-driven diagnostics at scale. As Verily continues to refine its data-centric model, the focus will likely remain on achieving sustainable, long-term health impact while maintaining its status as a leader in the digital transformation of the global healthcare industry.

See full Verily company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
Financial SoftwareSoftware
Customer Engagement PlatformsSoftwareAdvertising NetworksBusiness Services
Business Intelligence (BI) SoftwareSoftwareEngineering Software

Frequently Asked Questions Regarding Verily Financial Insights

What are the most recent funding rounds that Verily has completed, and what were the funding rounds?
Verily has recently completed 3 funding rounds: Other Financing Round on Mar 19, 2026, Unspecified on Sep 9, 2022, Private Equity on Dec 17, 2020.
What is the total amount of funding Verily has raised to date?
Verily has raised a total of $3.8B in funding to date.
How many funding rounds has Verily completed?
Verily has completed 3 funding rounds.
How much funding did Verily raise in its most recent funding round?
Verily raised $300M in its most recent funding round.
Who are the lead investors in Verily's latest funding round?
The lead investor in Verily's latest funding round was Alphabet. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Verily's history?
The largest funding round in Verily's history was $1B.
See more information about Verily